Tailored PTSD therapy boosts Veterans' daily life
NCT ID NCT04407767
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a personalized version of cognitive processing therapy (CF-CPT) for veterans with PTSD. 179 veterans participated to see if tailoring therapy to individual needs improves daily functioning, quality of life, and treatment completion compared to standard therapy. The goal was to help veterans engage better and achieve more holistic recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
179 people
The number who actually took part.
- Started
-
Mar 2021
- Finished
-
Aug 2025
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Veterans with posttraumatic stress disorder (PTSD) Exclusion Criteria: * Study exclusion criteria include active suicidal ideation with intent, homicidality, current mania, psychosis, or serious drug or alcohol abuse that requires immediate medical attention (e.g. inpatient care) * Patients should not be participating in another trauma-focused therapy at the time of enrollment but can continue any psychiatric medications (dose must be stable for one month prior to enrollment)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Posttraumatic stress disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030-4211, United States
-
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417, United States
-
Phoenix VA Health Care System, Phoenix, AZ
Phoenix, Arizona, 85012, United States
-
Salem VA Medical Center, Salem, VA
Salem, Virginia, 24153-6404, United States
-
Southeast Louisiana Veterans Health Care System, New Orleans, LA
New Orleans, Louisiana, 70119, United States
-
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
St Louis, Missouri, 63106-1621, United States
-
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817, United States
-
VA Pacific Islands Health Care System, Honolulu, HI
Honolulu, Hawaii, 96819-1522, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI decode how trauma therapy heals?
- Can a Two-Day couples retreat ease PTSD?
- Can community health workers help trauma survivors heal?
- Can a blood pressure drug rewrite trauma memories to ease fibromyalgia?
- Can adding social support to trauma therapy ease PTSD in youth?
- Can ketamine rewire fear memories to ease PTSD?